mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.008 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.009 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.009 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.01 |